logo
Deadly flesh-eating bacteria in Florida waters: Vibrio cases decline; danger persists

Deadly flesh-eating bacteria in Florida waters: Vibrio cases decline; danger persists

Miami Herald16-07-2025
Four people in Florida have died this year from Vibrio vulnificus, a rare flesh-eating bacterium found in warm, brackish seawater, among 11 confirmed cases, according to state health officials.
CBS Miami reports the number is down from 2024, when infections peaked with 82 cases and 19 deaths. Health officials linked that spike to Hurricane Helene.
Since 2016, Florida has recorded 448 cases and 100 deaths tied to the bacteria.
The 2025 deaths have been reported in Bay, Broward, Hillsborough, and St. Johns counties. Additional cases have also been confirmed in Duval, Escambia, Lee, Manatee, Santa Rosa, and Walton counties, as well as a second case in St. Johns.
Vibrio vulnificus infections are uncommon, but the Centers for Disease Control and Prevention estimates about 80,000 Vibrio cases and 100 related deaths occur each year in the United States.
The bacterium poses a heightened risk to individuals with weakened immune systems or chronic health conditions.
Here are some key facts about Vibrio vulnificus, according to the CDC:
How infection happens
Eating raw or undercooked shellfish, especially oystersExposing open wounds to warm salt or brackish waterNo evidence of person-to-person transmission
How it is diagnosed
Through stool, wound, or blood culturesLabs should be notified in advance to use the correct growth mediumPhysicians should suspect Vibrio in patients with gastrointestinal symptoms or wound infections following seafood consumption or seawater exposure
Symptoms
Watery diarrhea, vomiting, and abdominal painSkin infections from wounds exposed to seawaterIn severe cases: skin breakdown, ulcers, and bloodstream infections
What illnesses it can cause
Gastrointestinal illness: vomiting, diarrhea, and abdominal painWound infections: can lead to ulcers, tissue damage, and, in severe cases, amputationBloodstream infections: potentially fatal, with symptoms such as fever, chills, low blood pressure, and blistering skin lesionsPeople with weakened immune systems or chronic liver disease are at much higher risk
How to reduce your risk
Avoid raw oysters and shellfish; always cook seafood thoroughlyPrevent cross-contamination between raw and cooked seafoodKeep open wounds away from warm salt or brackish waterWear gloves when handling raw shellfish or seafoodRefrigerate leftovers promptly and safely
How it is treated
Immediate antibiotic treatment is criticalWound care is essential; in severe cases, amputation may be necessary
For more information, visit the CDC's Vibrio page.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy

Miami Herald

time16 minutes ago

  • Miami Herald

Covid-19 drug company liquidates assets in Chapter 11 bankruptcy

When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

RFK Jr. greenlights removing preservative from flu shots
RFK Jr. greenlights removing preservative from flu shots

Axios

time16 minutes ago

  • Axios

RFK Jr. greenlights removing preservative from flu shots

The Health and Human Services Department on Wednesday said it adopted a recommendation from Secretary Robert F. Kennedy Jr.'s vaccine advisers to remove from all influenza shots a preservative that anti-vaccine activists have suggested is linked to autism. Why it matters: The move hinged on the widely discredited belief that the mercury-containing compound, thimerosal, is harmful at the level at which it's included in vaccines. Despite the lack of evidence of harm, most Americans who get flu vaccines already receive products without thimerosal. The latest: Kennedy, in a statement, said the action fulfilled a promise to protect vulnerable populations from unnecessary mercury exposure. "Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility," Kennedy said. "Today, we put safety first." The Centers for Disease Control customarily acts on such recommendations. But because the CDC lacks a full-time political leader, Kennedy signed the recommendation. HHS said that vaccine manufacturers confirmed that they have the capacity to replace multi-dose vials containing the preservative so that the federal Vaccines for Children program and adult vaccine supplies won't be interrupted. Kennedy's handpicked vaccine advisors voted 5-1 last month to no longer recommend that that Americans get flu shots containing thimerosal, following a presentation from a retired nurse and former president of Children's Health Defense, the anti-vaccine group with close ties to Kennedy.

Officials detect EEE in mosquito sample in Belchertown, the state's first positive test this year
Officials detect EEE in mosquito sample in Belchertown, the state's first positive test this year

Boston Globe

time16 minutes ago

  • Boston Globe

Officials detect EEE in mosquito sample in Belchertown, the state's first positive test this year

According to the CDC, approximately 30 percent of people who develop severe EEE die, and many survivors have ongoing neurologic problems. The disease is generally spread to humans through the bite of an infected mosquito, officials said. Advertisement In 2019, 12 Officials advised residents to avoid mosquito bites by applying insect repellent, draining stagnant water, and being aware of peak mosquito hours — dusk to dawn, officials said. 'EEE activity in Massachusetts tends to occur in outbreak cycles,' said Dr. Catherine M. Brown, the state's epidemiologist. 'When EEE is found in mosquitos at this point in the season, the risk may increase throughout the rest of the summer.' Truman Dickerson can be reached at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store